Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551872 · ClinicalTrials.gov registry record · NA
RESILIENCE: Personalizing Cardiovascular Health
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 598
- Enrollment target
NCT04551872 is a NA study that has completed, run by Duke University. The registered enrollment target is 598 participants.
The verdict
NCT04551872, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 598 participants
- Enrollment target
Study Summary
Obesity is a rapidly growing epidemic that is associated with the development of cardiovascular disease (CVD). However, some individuals with obesity appear to be resistant to CVD, and other individuals demonstrate resilience to obesity and CVD risk factors. The investigator's overall objective is to understand factors contributing to the heterogeneity of CVD resistance and resilience among individuals with obesity at Duke.
Interventions
- BEHAVIORAL Digital weight loss intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2024-03-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04551872
The ClinicalTrials.gov registry entry for NCT04551872 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 598 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digital weight loss intervention is the first listed.
NCT04551872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04551872 about?
NCT04551872 is a clinical study titled "RESILIENCE: Personalizing Cardiovascular Health". Obesity is a rapidly growing epidemic that is associated with the development of cardiovascular disease (CVD). However, some individuals with obesity appear to be resistant to CVD, and other individuals demonstrate resilience to obesity and CVD risk factors. The investigator's overall objective is t...
What is the current status of trial NCT04551872?
This trial is currently completed. It is a NA study. The enrollment target is 598 participants. The study started on 2020-09-22. Estimated completion is 2024-03-22.
What interventions are being tested in trial NCT04551872?
The interventions under investigation include: Digital weight loss intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04551872?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.